Legislation prohibiting pharmacists from substituting any anti-epileptic drug for the prescribed anti-epileptic drug without notification and informed consent of the prescriber and patient has been "held for consideration" in a New York Assembly Higher Education Committee. This comes after a vote was scheduled to take place on Tuesday, June 3.
New York residents are encouraged to email their local representatives, as well as Higher Education Chairwoman Deborah Glick (firstname.lastname@example.org), and ask them to pass A9303. Talking points can be found on the AED Issues page.
For questions, please don't hesitate to contact Tim Miller, AAN Health Policy Analyst, at email@example.com or at (651) 695-2792.